Company intelligence / Profile preview

Aesir Capital

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Aesir Capital is a specialized investment management firm that focuses on the healthcare and life sciences sectors. The firm primarily engages in public and private equity investments, leveraging deep industry expertise to identify undervalued opportunities in biotechnology, pharmaceuticals, and medical technology. Aesir Capital is known for its fundamental research-driven approach and its role in providing strategic capital to emerging healthcare companies. By focusing on innovation and clinical validation, the firm aims to generate superior returns while supporting the development of transformative medical therapies.

Industry: Investors

Beyond the preview

Go deeper on Aesir Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aesir Capital.

Explore the full profile